The Trump administration is getting ready to put out an executive order on drug pricing that might look a lot different from President Donald Trump’s earlier remarks about the pharmaceutical industry.
Trump has said that drugmakers are “getting away with murder,” and has expressed an interest in negotiating drug prices, something the government isn’t allowed to do for Medicare and Medicaid.
Later in January, Trump met with the heads of pharma companies, where he reiterated his interest in bringing drug prices down in the US. In March, Trump also tweeted that he’s working on “a new system where there will be competition in the drug industry.” Since then, Trump hasn’t said much on the topic.
The executive order, however, might be a lot more in favor of drug companies than Trump’s previous comments have been, according to reports from Kaiser Health News and Politico.
The “Drug Pricing and Innovation Working Group,” a group of officials from the Trump administration, have been meeting every two weeks to talk about drug pricing. The group’s led by Joe Grogan, an associate director at the Office of Management and Budget who up until March worked for Gilead Sciences.
Here’s what’s to …read more
Source:: …read more
Source:: Fresh News – Business